Allergy

Allergy is a disorder of the immune system that is often called atopy. Allergic reactions occur to environmental substances known as allergens; these reactions are acquired, predictable and rapid. Strictly, allergy is one of four forms of hypersensitivity and is called type I hypersensitivity. It is characterized by excessive activation of certain white blood cells called mast cells and basophils by a type of antibody, known as IgE, resulting in an extreme inflammatory response. Common allergic reactions include eczema, hives, hay fever, asthma, food allergies, and reactions to the venom of stinging insects such as wasps and bees.Mild allergies like hay fever, are highly prevalent in the human population and cause symptoms such as allergic conjunctivitis and runny nose. Similarly, conditions such as asthma are common, in which allergy plays a major role. In some people, severe allergies to environmental or dietary allergens, or to medication, occur that may result in life-threatening anaphylactic reactions and potentially death.A variety of tests now exist to diagnose allergic conditions; these include testing the skin for responses to known allergens or analyzing the blood for the presence and levels of allergen-specific IgE. Treatments for allergies include allergen avoidance, use of antihistamines, steroids or other oral medications, immunotherapy to desensitize the response to allergen, and targeted therapy. (From the Wikpedia article Allergy.)

Download PDF containing detailed information.

Recent Publications on Allergy:
Block copolymers have different adjuvant effects on the primary immune response elicited by genetic immunization and on further induced allergy. Block copolymers were recently used to promote gene delivery in various...	20th November, 2009	INRA, UR496, Unite d'Immuno-Allergie Alimentaire, F-78352 Jouy-en-Josas,	Clin Vaccine Immunol. 2009 Nov 18. DOI Direct Link
Fusarium proliferatum Soft Tissue Infection at the Site of Plant Trauma: Recovery, Isolation, and Direct Molecular Identification. A 49-year-old man after allogeneic stem cell transplantation developed...	20th November, 2009	National Institute of Allergy and Infectious Diseases, National Institutes	J Clin Microbiol. 2009 Nov 18. DOI Direct Link
Newcastle disease virus-vectored vaccines expressing the hemagglutinin or neuraminidase protein of H5N1 highly pathogenic avian influenza virus protect against virus challenge in monkeys. H5N1 highly pathogenic avian influenza virus (HPAIV) causes periodic...	20th November, 2009	Laboratory of Infectious Diseases, National Institute of Allergy and	J Virol. 2009 Nov 18. DOI Direct Link
Breadth of HIV-Specific Neutralizing Activity in Sera: Clustering Analysis and Association with Clinical Variables. Induction of antibodies that neutralize a broad range of HIV-1 isolates is...	20th November, 2009	Laboratory of Immunoregulation, Vaccine Research Center, and Biostatistics	J Virol. 2009 Nov 18. DOI Direct Link
Effects of glycation of the model food allergen ovalbumin on antigen uptake and presentation by human dendritic cells. Advanced glycation endproducts (AGEs) of food proteins resulting from the...	20th November, 2009	Department of Dermatology, University of Mainz, Mainz, Germany.	Immunology. 2009 Nov 17. DOI Direct Link
→View more research publications.

Press Releases About Allergy:
MinuteClinic Opens First Retail Clinic in Washington, D.C. at CVS/pharmacy Store in Northeast	24th November, 2009	MinuteClinic	WASHINGTON, Nov. 24 /PRNewswire/ -- MinuteClinic, the pioneer and largest provider of retail-based health care in the United States, has opened its first retail health care center in Washington, D.C.
Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines	20th November, 2009	Soligenix, Inc.	PRINCETON, N.J., Nov. 20 /PRNewswire-FirstCall/ -- Soligenix, Inc. (OTC Bulletin Board: SNGX) (Soligenix or the Company), formerly known as DOR BioPharma, Inc., a late-stage biotechnology company,
/C O R R E C T I O N -- Education for Health/	18th November, 2009		LONDON, November 18 /PRNewswire/ -- In the news release, "Mainstay of the Global Workforce - 40-65 Year Olds - Hit Hardest by Chronic Obstructive Pulmonary Disease (COPD)" issued on 18 Nov
Mainstay of the Global Workforce - 40-65 Year Olds - Hit Hardest by Chronic Obstructive Pulmonary Disease (COPD)	18th November, 2009		LONDON, November 18 /PRNewswire/ -- COPD Uncovered, a new report issued today reveals for the first time that people between the ages of 40 to 65 are emerging as the new face of this disease. Authored
Cleaning Up Indoor Air Quality: New Certification Standard for Cleaning Products Will Help Millions of People Make More Educated Choices	18th November, 2009	The Asthma and Allergy Foundation of America	WASHINGTON, Nov. 18 /PRNewswire-USNewswire/ -- The growing asthma & allergy friendly(TM) Certification Program announced today that it has developed and adopted a certification standard and

BioNews Results for Allergy:
ENT and Allergy Associates Opens Offices in Edison and Old Bridge Further Expanding Its Commitment to New Jers	Genetic Engineering News:  Nov 20 2009 6:25PM Matching: allergy
An overview of delayed pressure urticaria with special emphasis on pathogenesis and treatment	MDLinx:  Nov 20 2009 11:06AM Matching: allergy
NIAD Awards to Study the Effects of Radiation	Medicexchange.com:  Nov 19 2009 9:08PM Matching: allergy
Have Egg Allergy? You May Still Be Candidate for Flu Vaccines, Says Allergist	Newswise:  Nov 19 2009 2:48AM Matching: allergy
Annals Of Allergy, Asthma And Immunology To Be Published By Elsevier	Medical News Today:  Nov 18 2009 7:27PM Matching: allergy
Promote your company here: BioNewsCast - Press Release Distribution	→View more news.

Allergy Clinical Trials:
An Observational Study of Childhood Food Allergy

Allergy Patents:
US Patent No.	Title
7612084	Amine derivatives for the treatment of asthma and COPD
7615213	Antibodies against human interleukin-13 and pharmaceutical compositions thereof
7615223	Selected immunoconjugates for binding to aminophospholipids
7615227	Use of CpG oligodeoxynucleotides to induce angiogenesis
7615237	Percutaneously absorbable preparations
→View more patents.

Companies working in the area of Allergy from Bioportfolio's Biocorporate database :
Company Name
Alerchek Incorporated ALerCHEK is a developer and manufacturer of immunoassay based diagnostic kits and components. Current immunoassay products include human and canine/feline allergy blood tests for over 200 different...         View full profile
ALK Abello A/S ALK Abello develops, produces and distributes effective, innovative products for the diagnosis, prevention, relief of allergic symptoms and cure of allergies. ALK Abello's R&D activities... www.alk-abello.com/        View full profile
GenVec GenVec, Inc. (NASDAQ: GNVC) is a biopharmaceutical company developing novel gene-based therapeutic drugs and vaccines. Each of our gene-based therapeutic product candidates use a common patent... www.genvec.com/        View full profile
→View more Allergy related companies.

BioPortfolio Ltd. offers e-mail and postal lists for Allergy scientists - we have details of around 6902 individuals working on Allergy .